Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - OTHER FINANCING ACTIVITIES
Other Financing Activities APLS - Apellis Pharmaceuticals, Inc.
10.1 M
LAST VALUE
-7.71%
2 YEAR CAGR
70.14%
5 YEAR CAGR
3.12%
10 YEAR CAGR